Results 31 to 40 of about 7,983,647 (299)

Evaluation of Pathological Response in Post-Neoadjuvant Chemotherapy Breast Carcinoma Specimens using Residual Cancer Burden System [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Many systems have been proposed to classify the degree of tumour response to therapy in post-neoadjuvant Chemotherapy (NACT) breast cancers. The Residual Cancer Burden (RCB) developed by MD Anderson cancer hospital is an online tool for
Lakshmi Manasa Perubhotla, Suseela Kodandapani, Sudha S Murthy   +2 more
doaj   +1 more source

Pathological responses and survival outcomes in patients with locally advanced breast cancer after neoadjuvant chemotherapy: a single-institute experience

Journal of the Egyptian National Cancer Institute, 2021
Background Pathological complete response (pCR) is a surrogate for the efficacy of neoadjuvant chemotherapy (NCT) in locally advanced breast cancer (LABC).
Kyrillus S. Shohdy, Doaa S. Almeldin, Madonna A. Fekry, Mahmoud A. Ismail, Nedal A. AboElmaaref, Esraa G. ElSadany, Baher M. Hamza, Fatma H. El-Shorbagy, Ahmad S. Ali, Hanaa Attia, Loay Kassem   +10 more
doaj   +1 more source

A case of retroperitoneal dedifferentiated liposarcoma successfully treated by neoadjuvant chemotherapy and subsequent surgery

Surgical Case Reports, 2020
Background Retroperitoneal liposarcoma (RPLS) is the most commonly observed soft tissue sarcoma in the retroperitoneal space. Although the beneficial effect of chemotherapy for RPLS is controversial, there are some reports that have shown a considerable ...
Yukihiro Yokoyama, Yoshihiro Nishida, Kunihiro Ikuta, Masato Nagino   +3 more
doaj   +1 more source

Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue [PDF]

, 2014
Five-year survival for patients with oral cancer has been disappointingly stable during the last decades, creating a demand for new biomarkers and treatment targets.
Philip John Coates, Torben Wilms, Laurell, Göran,, Rentoft, Matilda,, Coates, Philip John, Matilda Rentoft, Lotta Loljung, Göran Laurell, Karin Nylander, Rentoft, Matilda, Laurell, Göran, Wilms, Torben, Loljung, Lotta, Nylander, Karin, Loljung, Lotta,, Wilms, Torben,, Nylander, Karin,, Coates, Philip John,   +17 more
core   +1 more source

Analysis on complete pathological response and estimated survival among breast cancer patients undergoing neoadjuvant chemotherapy in a private institution in the state of Rio de Janeiro

, 2021
Objective: Breast cancer is the most common malignancy among women, both in developed and in developing countries. Indications for neoadjuvant treatment have been expanded so that pathological responses can be evaluated.
Letícia Morais C. O. Sermoud, Dante Pagnoncelli, Gustavo Buscacio, Luiz Henrique Araujo, Lilian Campos Lerner, Thamirez de Almeida Vieira Ferreira, Maria de Fátima Dias Gaui   +6 more
core   +1 more source

Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literature

Surgical Case Reports, 2018
Background The oncological effectiveness of preoperative radiotherapy for locally advanced colon cancer is unclear. We report a case of pathological complete response in a patient with locally advanced ascending colon cancer after preoperative ...
Sho Sekiya, Kiyotaka Imamura, Shintaro Takeuchi, Koichi Teramura, Yusuke Watanabe, Eiji Tamoto, Minoru Takada, Yoshihiro Kinoshita, Yoshiyasu Anbo, Fumitaka Nakamura, Nobuichi Kashimura, Hiroko Noguchi, Katsutoshi Miura, Satoshi Hirano   +13 more
doaj   +1 more source

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning

Breast Cancer Research, 2023
Background Invasive breast cancer patients are increasingly being treated with neoadjuvant chemotherapy; however, only a fraction of the patients respond to it completely.
Witali Aswolinskiy, Enrico Munari, Hugo M. Horlings, Lennart Mulder, Giuseppe Bogina, Joyce Sanders, Yat-Hee Liu, Alexandra W. van den Belt-Dusebout, Leslie Tessier, Maschenka Balkenhol, Michelle Stegeman, Jeffrey Hoven, Jelle Wesseling, Jeroen van der Laak, Esther H. Lips, Francesco Ciompi   +15 more
doaj   +1 more source

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast [PDF]

, 2008
Introduction To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer ...
Sinn, Hans-Peter, Sibylle Loibl, Jens-Uwe Blohmer, Jörn Hilfrich, Eidtmann, Holger, Jackisch, Christian, Minckwitz, Gunter von, Elisabeth Merkle, Hilfrich, Jörn, Caputo, Angelika, Angelika Caputo, Merkle, Elisabeth, Dan Costa, Serban, Blohmer, Jens-Uwe, Gunter von Minckwitz, Raab, Günter, German Breast Group (GBG), [Study group], Christian Jackisch, Hans-Peter Sinn, Serban D Costa, Holger Eidtmann, Loibl, Sibylle, Manfred Kaufmann, von Minckwitz, Gunter, null null, Günter Raab, Costa, Serban D., Kaufmann, Manfred   +27 more
core   +2 more sources

Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer

Namık Kemal Tıp Dergisi, 2021
Aim:In our study, we aimed to determine the clinicopathological factors affecting the pathological response after neoadjuvant chemotherapy in HER2 positive breast cancer.Materials and Methods:A total of 54 HER2 expression positive cases were included in ...
Abdullah Evren YETİŞİR, Semra PAYDAŞ
doaj   +1 more source

The Pathologic Complete Response Open Question in Primary Therapy [PDF]

JNCI Monographs, 2011
Accurate pathological diagnosis of tumor mass before treatment and careful examination of specimens after treatment are two main objectives in the diagnostic process of neoadjuvant-treated breast cancer. To achieve the first objective, multiple core biopsies can be taken to assess intratumor heterogeneity and thus to address a more targeted therapeutic
MARCHIO', Caterina, SAPINO, Anna
openaire   +3 more sources